TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING INCIDENCE OF TRAUMA CASES
4.2.2 RISING ADOPTION OF SEDENTARY LIFESTYLE
4.3 RESTRAINTS
4.3.1 RISKS ASSOCIATED WITH THROMBOSIS DRUGS
4.4 OPPORTUNITIES
4.4.1 NEW PRODUCT APPROVALS AND LAUNCHES
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION AND SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL THROMBUS TREATMENT MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON PRODUCTION
5.3.3 DEMAND-SUPPLY GAP ANALYSIS
5.3.4 IMPACT ON PRICING
5.4 NUMBER OF PROCEDURES FOR PULMONARY EMBOLISM
6 GLOBAL THROMBUS TREATMENT MARKET, BY TYPE
6.1 OVERVIEW
6.2 ATRIAL THROMBUS
6.3 VENOUS THROMBUS
7 GLOBAL THROMBUS TREATMENT MARKET, BY TREATMENT
7.1 OVERVIEW
7.2 MEDICAL THERAPY
7.3 SURGERY
7.4 OTHERS
8 GLOBAL THROMBUS TREATMENT MARKET, BY REGION
8.1 OVERVIEW
8.1.1 NORTH AMERICA
8.1.1.1 US
8.1.1.2 CANADA
8.1.2 EUROPE
8.1.2.1 GERMANY
8.1.2.2 UK
8.1.2.3 FRANCE
8.1.2.4 ITALY
8.1.2.5 SPAIN
8.1.2.6 REST OF EUROPE
8.1.3 ASIA-PACIFIC
8.1.3.1 JAPAN
8.1.3.2 CHINA
8.1.3.3 INDIA
8.1.3.4 AUSTRALIA
8.1.3.5 SOUTH KOREA
8.1.3.6 REST OF ASIA-PACIFIC
8.1.4 REST OF THE WORLD
8.1.4.1 MIDDLE EAST
8.1.4.2 AFRICA
8.1.4.3 LATIN AMERICA
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPETITIVE BENCHMARKING
9.3 MAJOR GROWTH STRATEGY IN THE GLOBAL THROMBUS TREATMENT MARKET
9.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL THROMBUS TREATMENT MARKET
9.5 KEY DEVELOPMENT ANALYSIS
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
9.6.1 PRODUCT APPROVALS/PRODUCT LAUNCHES
9.6.2 PARTNERSHIP/COLLABORATION
9.7 MAJOR PLAYERS FINANCIAL MATRIX
9.7.1 SALES (USD MILLION), 2021
9.7.2 R&D (USD MILLION), 2021
10 COMPANY PROFILES
10.1 TEVA PHARMACEUTICAL INDUSTRIES LTD.
10.1.1 COMPANY OVERVIEW
10.1.2 FINANCIAL ANALYSIS
10.1.3 PRODUCTS OFFERED
10.1.4 KEY DEVELOPMENTS
10.1.5 SWOT ANALYSIS
10.1.6 KEY STRATEGIES
10.2 SANOFI
10.2.1 COMPANY OVERVIEW
10.2.2 FINANCIAL OVERVIEW
10.2.3 PRODUCTS OFFERED
10.2.4 KEY DEVELOPMENTS
10.2.5 SWOT ANALYSIS
10.2.6 KEY STRATEGIES
10.3 PFIZER INC.
10.3.1 COMPANY OVERVIEW
10.3.2 FINANCIAL OVERVIEW
10.3.3 PRODUCTS OFFERED
10.3.4 KEY DEVELOPMENTS
10.3.5 SWOT ANALYSIS
10.3.6 KEY STRATEGIES
10.4 BAYER AG
10.4.1 COMPANY OVERVIEW
10.4.2 FINANCIAL OVERVIEW
10.4.3 PRODUCTS OFFERED
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIES
10.5 ANGIODYNAMICS.
10.5.1 COMPANY OVERVIEW
10.5.2 FINANCIAL OVERVIEW
10.5.3 PRODUCTS OFFERED
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIES
10.6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
10.6.1 COMPANY OVERVIEW
10.6.2 FINANCIAL OVERVIEW
10.6.3 PRODUCTS OFFERED
10.6.4 KEY DEVELOPMENTS
10.6.5 SWOT ANALYSIS
10.6.6 KEY STRATEGIES
10.7 BRISTOL-MYERS SQUIBB COMPANY
10.7.1 COMPANY OVERVIEW
10.7.2 FINANCIAL OVERVIEW
10.7.3 PRODUCTS OFFERED
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIES
10.8 ASPEN HOLDINGS
10.8.1 COMPANY OVERVIEW
10.8.2 FINANCIAL OVERVIEW
10.8.3 PRODUCTS OFFERED
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIES
10.9 JOHNSON & JOHNSON SERVICES, INC.
10.9.1 COMPANY OVERVIEW
10.9.2 FINANCIAL OVERVIEW
10.9.3 PRODUCTS OFFERED
10.9.4 KEY DEVELOPMENTS
10.9.5 SWOT ANALYSIS
10.9.6 KEY STRATEGIES
10.10 DAIICHI SANKYO COMPANY, LIMITED
10.10.1 COMPANY OVERVIEW
10.10.2 FINANCIAL OVERVIEW
10.10.3 PRODUCTS OFFERED
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIES
11 APPENDIX
11.1 REFERENCES
11.2 RELATED REPORTS
LIST OF TABLESTABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 NUMBER OF PROCEDURES FOR PULMONARY EMBOLISM, BY REGION (2021)
TABLE 4 GLOBAL THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 5 GLOBAL THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY REGION, 2018–2030 (USD MILLION)
TABLE 6 GLOBAL THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)
TABLE 7 GLOBAL THROMBUS TREATMENT MARKET, FOR RIGHT ATRIAL THROMBUS, BY REGION, 2018–2030 (USD MILLION)
TABLE 8 GLOBAL THROMBUS TREATMENT MARKET, FOR LEFT ATRIAL THROMBUS, BY REGION, 2018–2030 (USD MILLION)
TABLE 9 GLOBAL THROMBUS TREATMENT MARKET, FOR VENOUS THROMBUS, BY REGION, 2018–2030 (USD MILLION)
TABLE 10 GLOBAL THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 11 GLOBAL THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY REGION, 2018–2030 (USD MILLION)
TABLE 12 GLOBAL THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)
TABLE 13 GLOBAL THROMBUS TREATMENT MARKET, FOR ANTIPLATELETS BY TYPE, 2018–2030 (USD MILLION)
TABLE 14 GLOBAL THROMBUS TREATMENT MARKET, FOR ANTICOAGULANTS BY TYPE, 2018–2030 (USD MILLION)
TABLE 15 GLOBAL THROMBUS TREATMENT MARKET, FOR THROMBOLYTICS BY TYPE, 2018–2030 (USD MILLION)
TABLE 16 GLOBAL THROMBUS TREATMENT MARKET, FOR SURGERY, BY REGION, 2018–2030 (USD MILLION)
TABLE 17 GLOBAL THROMBUS TREATMENT MARKET, FOR OTHERS, BY REGION, 2018–2030 (USD MILLION)
TABLE 18 GLOBAL: THROMBUS TREATMENT MARKET, BY REGION, 2018–2030 (USD MILLION)
TABLE 19 NORTH AMERICA: THROMBUS TREATMENT MARKET, BY COUNTRY, 2018–2030 (USD MILLION)
TABLE 20 NORTH AMERICA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 21 NORTH AMERICA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030
TABLE 22 NORTH AMERICA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 23 NORTH AMERICA: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 24 US: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 25 US: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)
TABLE 26 US: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018-2030
TABLE 27 US: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 28 CANADA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 29 CANADA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030
TABLE 30 CANADA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 31 CANADA: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 32 EUROPE: THROMBUS TREATMENT MARKET, BY COUNTRY, 2018–2030 (USD MILLION)
TABLE 33 EUROPE: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 34 EUROPE: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)
TABLE 35 EUROPE: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 36 EUROPE: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)
TABLE 37 GERMANY: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 38 GERMANY: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)
TABLE 39 GERMANY: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 40 GERMANY: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)
TABLE 41 UK: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 42 UK: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)
TABLE 43 UK: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 44 UK: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)
TABLE 45 FRANCE: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 46 FRANCE: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)
TABLE 47 FRANCE: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 48 FRANCE: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)
TABLE 49 ITALY: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 50 ITALY: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)
TABLE 51 ITALY: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 52 ITALY: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)
TABLE 53 SPAIN: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 54 SPAIN: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)
TABLE 55 SPAIN: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 56 SPAIN: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)
TABLE 57 REST OF EUROPE: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 58 REST OF EUROPE: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)
TABLE 59 REST OF EUROPE: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 60 REST OF EUROPE: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)
TABLE 61 ASIA-PACIFIC: THROMBUS TREATMENT MARKET, BY COUNTRY, 2018–2030 (USD MILLION)
TABLE 62 ASIA-PACIFIC: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 63 ASIA-PACIFIC: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030
TABLE 64 ASIA-PACIFIC: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 65 ASIA-PACIFIC: THROMBUS TREATMENT MARKET FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 66 JAPAN: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 67 JAPAN: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68 JAPAN: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 69 JAPAN: THROMBUS TREATMENT MARKET FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 70 CHINA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 71 CHINA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72 CHINA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 73 CHINA: THROMBUS TREATMENT MARKET FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 74 INDIA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 75 INDIA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76 INDIA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 77 INDIA: THROMBUS TREATMENT MARKET FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 78 AUSTRALIA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 79 AUSTRALIA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80 AUSTRALIA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 81 AUSTRALIA: THROMBUS TREATMENT MARKET FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 82 SOUTH KOREA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 83 SOUTH KOREA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84 SOUTH KOREA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 85 SOUTH KOREA: THROMBUS TREATMENT MARKET FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 86 REST OF ASIA-PACIFIC: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 87 REST OF ASIA-PACIFIC: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88 REST OF ASIA-PACIFIC: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 89 REST OF ASIA-PACIFIC: THROMBUS TREATMENT MARKET FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 90 REST OF THE WORLD: THROMBUS TREATMENT MARKET, BY COUNTRY, 2018–2030 (USD MILLION)
TABLE 91 REST OF THE WORLD: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 92 REST OF THE WORLD: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030
TABLE 93 REST OF THE WORLD: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 94 REST OF THE WORLD: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 95 MIDDLE EAST: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 96 MIDDLE EAST: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030
TABLE 97 MIDDLE EAST: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 98 MIDDLE EAST: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 99 AFRICA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 100 AFRICA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030
TABLE 101 AFRICA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 102 AFRICA: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 103 LATIN AMERICA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 104 LATIN AMERICA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030
TABLE 105 LATIN AMERICA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 106 LATIN AMERICA: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)
TABLE 107 MAJOR PLAYERS IN THE GLOBAL THROMBUS TREATMENT MARKET
TABLE 108 MOST ACTIVE PLAYERS IN THE GLOBAL THROMBUS TREATMENT MARKET
TABLE 109 PRODUCT APPROVALS/PRODUCT LAUNCHES
TABLE 110 PARTNERSHIP/COLLABORATION
TABLE 111 TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS OFFERED
TABLE 112 TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY DEVELOPMENTS
TABLE 113 SANOFI: PRODUCTS OFFERED
TABLE 114 PFIZER INC.: PRODUCTS OFFERED
TABLE 115 BAYER AG: PRODUCTS OFFERED
TABLE 116 BAYER AG: KEY DEVELOPMENTS
TABLE 117 ANGIODYNAMICS.: PRODUCTS OFFERED
TABLE 118 ANGIODYNAMICS.: KEY DEVELOPMENTS
TABLE 119 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED
TABLE 120 BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS OFFERED
TABLE 121 BRISTOL-MYERS SQUIBB COMPANY: KEY DEVELOPMENTS
TABLE 122 ASPEN HOLDINGS: PRODUCTS OFFERED
TABLE 123 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED
TABLE 124 JOHNSON & JOHNSON SERVICES INC.: KEY DEVELOPMENTS
TABLE 125 DAIICHI SANKYO COMPANY, LIMITED: PRODUCTS OFFERED
| ※参考情報 血栓治療は、血液の塊である血栓が形成されることによって引き起こされるさまざまな疾患を治療するための手段です。血栓は、血管内で血液が固まることによって発生し、血流を妨げたり、完全に遮断したりすることがあります。これにより、心筋梗塞や脳梗塞、深部静脈血栓症などの重篤な病態を引き起こす可能性があります。血栓治療の目標は、血栓の形成を防止すること、既存の血栓を解消すること、及びそれに関連する合併症を減少させることです。 血栓治療の種類には、主に薬物療法、外科的治療、デバイス治療などがあります。薬物療法は血栓治療の中心であり、抗凝固薬と抗血小板薬が用いられます。抗凝固薬は、血液が固まるのを防ぐ薬であり、ワルファリンやNOAC（新しい経口抗凝固薬）等が含まれます。これらの薬は、心房細動の患者や静脈血栓塞栓症の予防に広く使用されています。 抗血小板薬は、血小板が集まるのを防ぐことで血栓の形成を抑制します。アスピリンやクロピドグレルなどがよく使われ、心疾患や脳血管障害の予防に役立ちます。薬物療法は比較的容易に実施できますが、出血リスクがあるため、慎重に使用する必要があります。 外科的治療としては、血栓摘除術や静脈弁の修復が挙げられます。血栓摘除術は、カテーテルを用いて血管内の血栓を直接取り除く方法で、急性の血栓症に対して有効です。また、動脈内血栓症に対しては、バルーンアンギオプラスティとステント留置が行われることがあります。この手法は、狭窄部位を拡張し、再び血流を確保することを目的としています。 最近では、デバイス治療も進化してきています。特に、血栓回収デバイスが注目されており、これにより血栓を物理的に除去することが可能になっています。血栓回収デバイスは、急性脳梗塞の治療において重要な役割を果たすようになっており、臨床研究でもその有効性が示されています。 血栓治療に関連する技術も多様化しており、画像診断技術がその一翼を担っています。例えば、超音波検査やCT、MRIを用いた診断は、血栓の位置や大きさを正確に把握するのに役立ちます。これにより、最適な治療法を選択するための情報が提供されます。 さらに、血栓治療において新たな治療法や技術が開発されています。例えば、再生医療に基づく細胞療法や、ナノテクノロジーを利用した薬剤のデリバリーシステムが研究されています。これにより、より効果的で安全な血栓治療が期待されています。 血栓治療は進化しており、医療分野での新しい技術や治療法の開発が継続されています。しかしながら、血栓症の予防や早期発見が最も重要であり、生活習慣の改善や定期的な健康診断が求められます。特に、喫煙や肥満、運動不足は血栓症のリスクを高める要因であり、これらのリスクを低下させることで、血栓の発生を抑制することが可能となります。血栓治療は、個々の患者の状態に応じて最適な戦略を立てることが大切であり、医療従事者との連携が重要です。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
